TRACY MARTIN: Open Payments
NPI 1275725582 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,116 in 23 payments from 13 companies in 2025. Trend: 2023 $1,406 · 2024 $1,032 · 2025 $2,116
Speaker / faculty: $1,305Food & beverage: $811
| Company | Payments | Amount |
|---|---|---|
| SANOFI-AVENTIS U.S. LLC | 3 | $1,474 |
| Incyte Corporation | 5 | $193 |
| Janssen Biotech, Inc. | 2 | $109 |
| Astellas Pharma US Inc | 2 | $65 |
| ABBVIE INC. | 2 | $48 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $46 |
| Novartis Pharmaceuticals Corporation | 1 | $35 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $29 |
| PFIZER INC. | 1 | $29 |
| SOBI, INC | 1 | $26 |
Products named: REZUROCK, NIKTIMVO, RYBREVANT, PLUVICTO, Xospata, Cresemba, TECVAYLI, Nubeqa.
Industry payments across TX — which companies pay providers there.
